Rivia is a Zurich-based technology company building a data engine that powers the future of clinical trial intelligence. Rivia was founded on the belief that new drugs can be brought to market more successfully with a fraction of today’s capital. Over the past two years, European and US based biotechs running global clinical trials on Rivia have demonstrated measurable impact, from earlier understanding of therapeutic potential to significantly more efficient trial execution. In the years ahead, the company will scale its platform and embedded intelligence to help bring groundbreaking therapies to market faster. Learn more at https://rivia.com
| Website | http://www.rivia.com |
| Employees | 34 (20 on RocketReach) |
| Founded | 2022 |
| Industry | Software Development |
| Keywords | Clinical Trials, Biotechnology, Data Analytics, Clinical Development, Trial Management, Ai Analytics, Therapeutic Development, Data Integration, Analytics Platform, Predictive Analytics, Drug Discovery, Machine Learning, Bioinformatics, Data Science, Platform, Big Data, Deep Learning, Software, Healthcare, Pharma |
| Competitors | OurCrowd, SeedInvest, AngelList, Crowdcube, Indiegogo, PANGEA, Audios, Caledonian Braves Football Club, StartEngine, EquityNet +32 more (view full list) |
Looking for a particular Rivia employee's phone or email?
Erik Scalfaro is the Co-Founder and CEO of Rivia.
20 people are employed at Rivia.